Company / Operating Income per Share
Intellia Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.32
FY2025
5-year range
-$6.15 / -$4.04
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#142 of 149
Health Care
What the data says
Among 149 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 5% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $-6.15 in FY2022 to $-4.32 in FY2025.
Based on SEC 10-K filings.
-4.32 in FY2025.
Improved from $-5.92 to $-4.32 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 149This company -$4.32 Sector average $4.30
▼
-200.5% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 24.8% year-over-year.
- Ranks #142 out of 149 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.32 | +24.8% |
| FY2024 | -$5.74 | +2.9% |
| FY2023 | -$5.92 | +3.8% |
| FY2022 | -$6.15 | -52.1% |
| FY2021 | -$4.04 | -48.6% |
| FY2020 | -$2.72 | -15.7% |
| FY2019 | -$2.35 | -9.7% |
| FY2018 | -$2.14 | -11.0% |
| FY2017 | -$1.93 | -33.5% |
| FY2016 | -$1.45 | +97.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026